You are currently on the new version of our website. Access the old version .

6 Results Found

  • Article
  • Open Access
6 Citations
7,169 Views
12 Pages

15 December 2017

Iron deficiency anemia is a common clinical consequence for people who suffer from chronic kidney disease, especially those requiring dialysis. Intravenous (IV) iron therapy is a widely accepted safe and efficacious treatment for iron deficiency anem...

  • Article
  • Open Access
1 Citations
1,781 Views
14 Pages

Intravenous Sodium Ferric Gluconate Complex for Hospitalized Pediatric Patients with Iron Deficiency Anemia

  • Felicia White,
  • Noelle Polakowski,
  • Elena Merlington,
  • Mara Leimanis,
  • Brooke Dudick,
  • Jessica Parker,
  • Ashley Jousma,
  • Alexander Loji,
  • Jeffrey Hanson and
  • Brian Boville
  • + 1 author

5 February 2025

Background/Objectives: Iron deficiency anemia is common in the pediatric population. Red blood cell transfusions, a common acute treatment, pose well-recognized risks including lung injury, circulatory overload, and immune dysfunction. Intravenous ir...

  • Article
  • Open Access
17 Citations
12,159 Views
18 Pages

Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Physicochemical Characterization

  • Dajun Sun,
  • Rodney Rouse,
  • Vikram Patel,
  • Yong Wu,
  • Jiwen Zheng,
  • Alokita Karmakar,
  • Anil K. Patri,
  • Priyanka Chitranshi,
  • David Keire and
  • Wenlei Jiang
  • + 1 author

5 January 2018

The objective of this study was to evaluate physicochemical equivalence between brand (i.e., Ferrlecit) and generic sodium ferric gluconate (SFG) in sucrose injection by conducting a series of comparative in vitro characterizations using advanced ana...

  • Article
  • Open Access
10 Citations
6,784 Views
15 Pages

Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Biodistribution after Intravenous Dosing in Rats

  • Christopher R. Beekman,
  • Murali K. Matta,
  • Christopher D. Thomas,
  • Adil Mohammad,
  • Sharron Stewart,
  • Lin Xu,
  • Ashok Chockalingam,
  • Katherine Shea,
  • Dajun Sun and
  • Rodney Rouse
  • + 2 authors

28 December 2017

Relative biodistribution of FDA-approved innovator and generic sodium ferric gluconate (SFG) drug products was investigated to identify differences in tissue distribution of iron after intravenous dosing to rats. Three equal cohorts of 42 male Spragu...

  • Article
  • Open Access
12 Citations
7,263 Views
12 Pages

Determination of Non-Transferrin Bound Iron, Transferrin Bound Iron, Drug Bound Iron and Total Iron in Serum in a Rats after IV Administration of Sodium Ferric Gluconate Complex by Simple Ultrafiltration Inductively Coupled Plasma Mass Spectrometric Detection

  • Murali K. Matta,
  • Christopher R. Beekman,
  • Adarsh Gandhi,
  • Suresh Narayanasamy,
  • Christopher D. Thomas,
  • Adil Mohammad,
  • Sharron Stewart,
  • Lin Xu,
  • Ashok Chockalingam and
  • Rodney Rouse
  • + 2 authors

11 February 2018

A rapid, sensitive and specific ultrafiltration inductively-coupled plasma mass spectrometry method was developed and validated for the quantification of non-transferrin bound iron (NTBI), transferrin bound iron (TBI), drug bound iron (DI) and total...

  • Article
  • Open Access
21 Citations
9,592 Views
10 Pages

Assessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA)

  • Susann Neiser,
  • Taija S. Koskenkorva,
  • Katrin Schwarz,
  • Maria Wilhelm and
  • Susanna Burckhardt

Intravenous iron preparations are typically classified as non-dextran-based or dextran/dextran-based complexes. The carbohydrate shell for each of these preparations is unique and is key in determining the various physicochemical properties, the meta...